COMMUNIQUÉS West-GlobeNewswire

Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology
22/03/2019
NORCROSS, Ga., March 22, 2019 (GLOBE NEWSWIRE) -- Providence Cancer Institute and Galectin Therapeutics Inc. (NASDAQ: GALT) , the leading developer of therapeutics that target galectin proteins, announced today a [...]
resTORbio, Inc. Announces Closing Public Offering of Common Stock
22/03/2019
BOSTON, March 22, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/03/2019
REDWOOD CITY, Calif., March 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective March 21, 2019, the compensation committee of the company’s board of directors granted [...]
Better Choice Company Appoints Four New Board of Director Members
22/03/2019
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTCQB: BTTRD) (the “Company”) today announced the appointment of Lori Taylor, Damian Dalla-Longa, Jeff Davis and Michael Galego to [...]
SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update
22/03/2019
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Wildflower Brands Featured in CannabisNewsWire Publication Discussing the Farm Bill’s Positive Effect on CBD Sales
22/03/2019
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted [...]
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
22/03/2019
NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Sun BioPharma Provides Business Update and Files Annual Report for 2018
22/03/2019
Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel enrolling second Cohort of Phase 1a Company reinstates founder and Executive Chairman, Dr. Michael Cullen as President and Chief Executive Officer, [...]
IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2019
22/03/2019
MONTREAL, March 22, 2019 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the six months ended January 31, 2019. “We were pleased with our [...]
Tauriga Sciences Inc. Now Shipping its CBD Infused Chewing Gum from its Fulfillment Facility!
22/03/2019
New York, NY, March 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Aptinyx to Present Preclinical Data on NYX-458 at the AD/PD 14th International Conference on Alzheimer’s & Parkinson’s Diseases
22/03/2019
EVANSTON, Ill., March 22, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
22/03/2019
SINGAPORE, March 22, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, today reported [...]
Sorrento Therapeutics Announces the Merger of Scilex and Semnur to Create a Global Leader in Non-Opioid Pain Management
22/03/2019
Semnur’s SP102, addressing multi-billion dollar unmet market needs, in Pivotal Phase 3 Trial with Fast Track Status from the FDA With non-opioid ZTlido, RTX, and SP102 commercial and near-commercial product lines, [...]
Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
22/03/2019
Company Announcement Type II variation application submitted to the EMA for daratumumab in combination with lenalidomide and dexamethasone as treatment for newly diagnosed multiple myeloma patients who are not [...]
Exactus Applauds CVS’s Decision to Sell CBD Products
22/03/2019
Exactus Inc. Anticipates Many More National Drugstores to Follow Suit DELRAY BEACH, Fla., March 22, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI / OTCQB:EXDID) , a healthcare company pursuing opportunities in Hemp [...]
Crown Bioscience présentera les dernières avancées en matière de plateformes précliniques et translationnelles à au congrès annuel de l'AACR 2019
22/03/2019
15 affiches présenteront les données des nouveaux modèles d'évaluation des nouveaux traitements du cancer SAN DIEGO, 22 mars 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de recherche et de [...]
Herantis Pharma Plc: Change in the number of shares and voting rights
22/03/2019
Herantis Pharma Plc: Change in the number of shares and voting rights Herantis Pharma Plc Company release 22 March 2019 at 10:00 am Herantis Pharma Plc (''Herantis'' or the ''Company'') announced a directed share issue [...]
Oncology Venture has established bridge loan facility
22/03/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that its share has received observation status by Nasdaq Stockholm AB, following the publication of its Annual [...]
RAMSAY GENERALE DE SANTE : lancement d'une augmentation de capital
22/03/2019
COMMUNIQUE DE PRESSE Ramsay Générale de Santé annonce le lancement d'une augmentation de capital avec maintien du droit préférentiel de souscription de 625 millions d'euros environ dans le cadre du refinancement de l' [...]

Pages